Published in J Pharm Sci on March 01, 1980
The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke (1998) 4.93
Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 4.55
Public perception of stroke warning signs and knowledge of potential risk factors. JAMA (1998) 4.21
Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A (1996) 2.54
Gap junction formation between reaggregated Novikoff hepatoma cells. Proc Natl Acad Sci U S A (1974) 2.30
Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke (1999) 2.28
Dippers and non-dippers. Lancet (1988) 2.28
Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke (1999) 2.21
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke (1999) 2.17
Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke (1998) 1.64
Diffusion model for fluidized-bed drying. J Pharm Sci (1975) 1.52
Comparison of midazolam and diazepam for conscious sedation in the emergency department. Ann Emerg Med (1993) 1.48
Identification and definition of long-stay mental hospital population. Br Med J (1975) 1.47
National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. Eur J Clin Microbiol Infect Dis (2000) 1.26
Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom Med (2001) 1.24
Stress-related immune suppression: health implications. Brain Behav Immun (1987) 1.18
Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology (2002) 1.13
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke (2000) 1.12
Directly observed treatment for tuberculosis. Could be provided by community pharmacists supervising consumption of methadone. BMJ (1996) 1.12
Effect of government recommendations on methadone prescribing in South East England: comparison of 1995 and 1997 surveys. BMJ (1998) 1.10
Congenital vertical talus and its familial occurrence: an analysis of 36 patients. Clin Orthop Relat Res (1979) 1.08
Reasons for delayed compliance with the childhood vaccination schedule and some failings of computerised vaccination registers. Aust N Z J Public Health (1999) 1.04
Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke (1999) 1.04
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Bone Marrow Transplant (2013) 1.04
Multiple sclerosis clustering in a small Massachusetts community, with possible common exposure 23 years before onset. N Engl J Med (1973) 1.03
Methods for the assessment of the stability of tablet disintegrants. J Pharm Sci (1991) 1.03
Clinical application of the Ottawa ankle rules for the use of radiography in acute ankle injuries: an independent site assessment. AJR Am J Roentgenol (1997) 1.02
Gap junctions between Novikoff hepatoma cells following dissociation and recovery in the absence of cell contact. J Ultrastruct Res (1981) 1.01
Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice. Infect Immun (1993) 0.99
Quality of hospital care in African American and white patients with ischemic stroke and TIA. Neurology (2006) 0.96
An exploratory randomized controlled trial comparing telephone and hospital follow-up after treatment for colorectal cancer. Colorectal Dis (2012) 0.95
Treatment of hyperkalaemia using intravenous and nebulised salbutamol. Arch Dis Child (1994) 0.94
Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance. Clin Infect Dis (2001) 0.92
Rapid method for purification of human T lymphocytes for further functional studies. J Immunol Methods (1987) 0.91
Human blink startle during aversive and nonaversive Pavlovian conditioning. J Exp Psychol Anim Behav Process (1994) 0.90
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors. Bone Marrow Transplant (2011) 0.89
Simultaneous determination of prednisolone acetate, prednisolone, prednisone, cortisone and hydrocortisone in swine plasma using solid-phase and liquid-liquid extraction techniques. J Chromatogr (1986) 0.89
Simple and selective high-performance liquid chromatographic method for the determination of hydrochlorothiazide in urine. J Chromatogr (1986) 0.89
Analysis of gap junctions and formation plaques between reaggregating Novikoff hepatoma cells. J Ultrastruct Res (1981) 0.88
Survival of Escherichia coli O157:H7 during the manufacture of pepperoni. J Food Prot (1998) 0.87
Greater Cincinnati/Northern Kentucky Stroke Study: volume of first-ever ischemic stroke among blacks in a population-based study. Stroke (2001) 0.87
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Ann Neurol (2001) 0.87
Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Pediatr Endocrinol Metab (2000) 0.87
Square root of time dependence of matrix formulations with low drug content. J Pharm Sci (1982) 0.85
Degradation mechanisms for water-soluble drugs in solid dosage forms. J Pharm Sci (1969) 0.85
Long-stay patients with long-stay drugs. A case review; a cause for concern. Lancet (1976) 0.85
Retinol and retinoic acid bind to a surface cleft in bovine beta-lactoglobulin: a method of binding site determination using fluorescence resonance energy transfer. Biophys Chem (1998) 0.85
Phenytoin I: in vitro-in vivo correlation for 100-mg phenytoin sodium capsules. J Pharm Sci (1983) 0.84
Letter: Aplastic amaemia and hair dye. Br Med J (1976) 0.84
Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5' end of the ER gene. Clin Cancer Res (2000) 0.83
The effect of adrenalectomy on the restraint stressed induced suppression of MHC class II expression by murine peritoneal macrophages. Brain Behav Immun (1993) 0.83
Stability of solids and solid dosage forms. J Pharm Sci (1974) 0.83
Age- and diet-related increase in transepithelial colon permeability of Fischer 344 rats. Dig Dis Sci (2002) 0.83
Transneuronal labeling in hamster brainstem following lingual injections with herpes simplex virus-1. Neuroscience (1995) 0.82
The sorption of water vapour by starch and the application of the Young and Nelson equations. J Pharm Pharmacol (1983) 0.82
Angular responses of the first and second diffracted orders in transmission diffraction grating recorded on photopolymer material. Opt Express (2003) 0.82
Life, death and genomic change in perturbed cell cycles. Philos Trans R Soc Lond B Biol Sci (1994) 0.82
Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vitro demonstration of an in vivo observation. J Pharm Sci (1986) 0.81
Prescribing amphetamines to drug misusers: data from the 1995 national survey of community pharmacies in England and Wales. Addiction (1997) 0.80
Dissolution testing of soft shell capsules-acetaminophen and nifedipine. J Pharm Sci (1997) 0.80
Osmolality--limits of physical tests. Dev Pharmacol Ther (1988) 0.80
Phenotypic differences in dextromethorphan metabolism. Pharm Res (1989) 0.80
Oral hydrocortisone pharmacokinetics: a comparison of fluorescence and ultraviolet high-pressure liquid chromatographic assays for hydrocortisone in plasma. J Pharm Sci (1982) 0.80
Colorectal cancer follow-up: patient satisfaction and amenability to telephone after care. Eur J Oncol Nurs (2010) 0.80
Nonlinear estimation of kinetic parameters for solid-state hydrolysis of water-soluble drugs. II: Rational presentation mode below the critical moisture content. J Pharm Sci (1990) 0.79
Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity. J Pharm Sci (1981) 0.79
Tray drying of pharmaceutical wet granulations. J Pharm Sci (1982) 0.79
Solid-state decomposition of alkoxyfuroic acids in the presence of microcrystalline cellulose. J Pharm Sci (1983) 0.79
Dissolution of a soluble drug substance from vinyl polymer matrices. J Pharm Sci (1983) 0.79
Thrombolytic therapy for stroke. Curr Opin Neurol (1994) 0.79
Bonding mechanisms and hysteresis areas in compression cycle plots. J Pharm Sci (1981) 0.79
Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study. Pharm Res (1987) 0.78
Methadone prescribing to opiate addicts by private doctors: comparison with NHS practice in south east England. Addiction (2001) 0.78
Tetanus neonatorum: clinico-epidemiological profile. Indian Pediatr (1988) 0.78
Bioavailability of hydrochlorothiazide from tablets and suspensions. J Pharm Sci (1984) 0.78
Dissolution profiles and specifications for dihydroergotoxine sublingual tablets using a new in vitro method. J Pharm Sci (1981) 0.78
The role of the community pharmacist in drug abuse: a comparison of service provision between Northern Ireland and England/Wales. Pharm World Sci (2001) 0.78
Mechanisms of VCAM-1 and fibronectin binding to integrin alpha 4 beta 1: implications for integrin function and rational drug design. Ciba Found Symp (1995) 0.78
Immunophenotypic diagnosis of acute leukemia by using decision tree induction. Lab Invest (1999) 0.78
Interactions in the solid state. I: Interactions of sodium bicarbonate and tartaric acid under compressed conditions. J Pharm Sci (1985) 0.77
Purification and characterization of a novel growth factor from human breast cancer cells. Biochemistry (1992) 0.77
Influence of dioctyl sodium sulfosuccinate on the absorption of tetracycline. Biopharm Drug Dispos (1986) 0.76
Thiazides XI: partitioning of chlorothiazide in red blood cells after oral administration. Biopharm Drug Dispos (1984) 0.76
Ulcerative colitis complicated by disseminated intravascular coagulation. Postgrad Med J (1987) 0.75
Rebuttal to "practical testing of solid-state stability of pharmaceuticals". J Pharm Sci (1993) 0.75
Duplex ultrasound scanning for diagnosing lower limb deep vein thrombosis. Dermatol Surg (1995) 0.75
Comparison of plasma and urine analyses for thiazides in bioavailability/bioequivalence study. J Pharm Sci (1981) 0.75
Statistical aspects of arrhenius plotting. Bull Parenter Drug Assoc (1972) 0.75
Pharmaceutics of cephapirin sodium (Cefadyl) a new semisynthetic cephalosporin - part III. Curr Ther Res Clin Exp (1974) 0.75
Coumermycin A1-Biopharmaceutical studies. II. J Pharm Sci (1970) 0.75
Kinetic salt effect in pharmaceutical investigations. J Pharm Sci (1970) 0.75
Bioavailability of hydrocortisone from commercial 20-mg tablets. J Pharm Sci (1984) 0.75
Nature of bonding in montmorillonite adsorbates. II. Bonding as an ion--dipole interaction. J Pharm Sci (1972) 0.75
Thermodynamic and kinetic aspects of parenteral benzodiazepines. Bull Parenter Drug Assoc (1972) 0.75
Solvation of montmorillonite. J Pharm Sci (1972) 0.75
Sedimentation kinetics of flocculated suspensions. II. Sedimentation below the critical height. J Pharm Sci (1970) 0.75
Effects of short-term moderate storage stress on the disintegration and dissolution of four types of compressed tablets. Pharm Acta Helv (1984) 0.75
Dissolution rate patterns of log-normally distributed powders. J Pharm Sci (1972) 0.75
Nature of bonding in montmorillonite adsorbates. I. Surface adsorption. J Pharm Sci (1971) 0.75